Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Glaxo recalls 1 lot of Emo-Cort lotion in Canada
Yahoo/AP
Saturday, October 30, 2010 - 12:30pm
tags:
GSK, Emo-Cort, eczema, dermatitis
J&J probes Crucell's manufacturing mishap
Yahoo/AP
Saturday, October 30, 2010 - 12:28pm
tags:
JNJ, Crucell
Is Provenge The Most Important Medicine In Biotech?
Forbes
Saturday, October 30, 2010 - 12:27pm
tags:
Provenge, Dendreon, prostate cancer
Idera Pharmaceuticals Presents Phase 1 Data on IMO-2125 Demonstrating Induction of Broad Antiviral Immune Response in Null-Responder HCV Patients
Yahoo/BusinessWire
Saturday, October 30, 2010 - 12:23pm
tags:
Idera Pharmaceuticals, IMO-2125, hepatitis C
Viread® for Hepatitis B Maintains Antiviral Suppression with No Development of Resistance Through Four Years of Treatment
Yahoo/BusinessWire
Saturday, October 30, 2010 - 12:22pm
tags:
Viread, Gilead Sciences, hepatitis B
ANA598 Data Presented at AASLD Highlight Positive Clinical Profile of DAA Entering Phase IIb
Yahoo/PR NewsWire
Saturday, October 30, 2010 - 12:16pm
tags:
hepatitis C, Anadys, ANA598
Diet Drug Optimism Lifts Shares of Vivus
NY Times
Saturday, October 30, 2010 - 12:14pm
tags:
Vivus, Qnexa, obesity
Bristol-Myers, Gilead Seek AIDS Cocktail Success in Hepatitis C
Bloomberg
Saturday, October 30, 2010 - 11:53am
tags:
Bristol-Myers Squibb, Gilead Sciences, HIV, hepatitis C
Questcor Pharmaceuticals Shares Popped: What You Need to Know
Motley Fool
Saturday, October 30, 2010 - 11:51am
tags:
Questcor Pharmaceuticals
Is Now The Time To Buy Pharmaceuticals?
Investopedia
Saturday, October 30, 2010 - 11:49am
tags:
Eli Lilly, Biogen Idec, Gilead Sciences
Biotech Calendar: Key Dates for November
TheStreet.com
Friday, October 29, 2010 - 12:11pm
tags:
biotech, Merck, Gilead Sciences, Indenix, Pharmasset, Bristol-Myers Squibb, Dendreon, Cadence Pharmaceuticals, Vical, MELA Sciences, Human Genome Sciences, Amgen
Shire Profit Rises on Vyvanse Sales, Genzyme Delays
Bloomberg
Friday, October 29, 2010 - 12:05pm
tags:
Shire, earnings
Drugmakers rack up $1B in small deals
Fierce Pharma
Friday, October 29, 2010 - 11:53am
tags:
M&A, Sanofi, BMP Sunstone, Teva Pharmaceuticals, Theramex, Merck KGaA, Hikma, Baxter International
U.S. Panel Debates Value of HPV Vaccine for Boys
NY Times, NY
Friday, October 29, 2010 - 11:51am
tags:
HPV, vaccines, Gardasil, Cervarix, GSK, Merck
Vivus Gains on Potential to Win U.S. Clearance for Obesity Drug Next Year
Bloomberg
Friday, October 29, 2010 - 11:49am
tags:
Qnexa, FDA, obesity, Vivus
Geron Q3 loss grows to $18.3M
Bizjournals.com
Friday, October 29, 2010 - 11:48am
tags:
earnings, Geron
Whither Diet Pills? Why The FDA Keeps Saying No
Pharmalot
Friday, October 29, 2010 - 11:45am
tags:
Vivus, Qnexa, obesity, diet pills, Arena Pharmaceuticals, FDA
GlaxoSmithKline licenses Amicus drug in $230M deal
Bizjournals.com
Friday, October 29, 2010 - 11:38am
tags:
Amicus Therapeutics, GSK, licensing, Amigal, Fabry's disease
Forest Labs says COPD drug meets study goal
Yahoo/AP
Friday, October 29, 2010 - 10:07am
tags:
COPD, Forest Labs, aclidinium bromide
J&J Has Nothing to Add to Public Statement Oct. 6 on Crucell
Bloomberg
Friday, October 29, 2010 - 10:05am
tags:
JNJ, Crucell, vaccines

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.